Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress

    NEXT STORY
    Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy
    PREV STORY
    PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company

    Company Announcement Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company ...

    author_avatar
    NASDAQ Market News

    Leading BioSciences Announces Top Line Phase 2 Data Demonstrating LB1148 Achieves Primary Endpoint with Statistically Significant Improvement in Bowel Function Following Cardiovascular Surgery

    author_avatar
    NASDAQ Market News

    BeiGene Reports Fourth Quarter and Full Year 2017 Financial Results

    CAMBRIDGE, Mass. and BEIJING, China, Feb. 28, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

    author_avatar
    NASDAQ Market News